Research Training
The Division of Child and Adolescent Psychiatry at Cincinnati Children’s has a strong interest in promoting clinical research experiences for residents. Residents may participate in a variety of research protocols with faculty members.
Ongoing Research Studies
Studies under way in the Division of Child and Adolescent Psychiatry include the following:
- Double-Blind, Placebo-Controlled Study of an Antidepressant in Children and Adolescents with Generalized Anxiety Disorder
- Clonidine in ADHD Treatment
- Acetylcholinesterase Inhibitor in Treatment of ADHD
- Use of a Transdermal Patch in the Treatment of ADHD
- Antipsychotic in the Treatment of Adolescents with Mania
- Adolescent Body Dysphormic Disorder
- A Selective Irreversible Inhibitor of MAO-B
- SSRI Open-Label Treatment of Depression
- Open Label Extension Study of an SSRI Treatment in Depressed Adolescents and Children
- Open Label, Long-Term Safety Study of an Antidepressant in Children and Adolescents with Major Depressive Disorder
- Evaluation of PK, Safety and Tolerability of an Antidepressant in Pediatric and Adult Patients with Depression
- Multi-center, Double-blind, Placebo-Controlled Study of an Antidepressant in Depressed Adolescents
- Multi-center Study to Assess the Pharmacokinetics of an Anti-depressant in Children and Adolescents diagnosed with Depression or OCD
- Multi-center, Open-label Study to Assess Long-term Safety of an Antidepressant in Children and Adolescents with Depression or OCD
- Genetic Differences in Response to a Clomipramine in Patients with Obsessive Compulsive Disorder (OCD)
- Pulse Loaded, I.V. Clomipramine in Unresponsive Obsessive-Compulsive Disorder
- Randomized, Multi-center, 10 week, Double-Blind, Placebo-Controlled Flexible-Dose Study to Evaluate the Efficacy and Safety of a SSRI in Children and Adolescents with OCD
- 16 week, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Tolerability of an SSRI in the Treatment of Children and Adolescents with Social Anxiety Disorder / Social Phobia
- Antiparkinsonian Drug in Treatment of Tourettes Syndrome
- Controlled Comparison of an Antipsychotic and a Neuroleptic Drug
